Socio-economic and corporate factors and COVID-19 pandemic: a wake-up call

Abstract

The novel coronavirus 2019 (COVID-19) emerges from the Chinese city Wuhan and its spread to the rest of the world, primarily affected economies and their businesses, leading to a global depression. The explanatory and cross-sectional regression approach assesses the impact of COVID-19 cases on healthcare expenditures, logistics performance index, carbon damages, and corporate social responsibility in a panel of 77 countries. The results show that COVID-19 cases substantially increase healthcare expenditures and decrease corporate social responsibility. On the other hand, an increase in the coronavirus testing capacity brings positive change in reducing healthcare expenditures, increased logistics activities, and corporate social responsibility. The cost of carbon emissions increases when corporate activities begin to resume. The economic affluence supports logistics activities and improves healthcare infrastructure. It linked to international cooperation and their assistance to supply healthcare logistics traded equipment through mutual trade agreements. The greater need to enhance global trade and healthcare logistics supply helps minimize the sensitive coronavirus cases that are likely to provide a safe and healthy environment for living.

Does money buy health? evaluation of stock market performance and economic growth in the wake of the COVID-19 pandemic

“…Subsidized trade policies would be beneficial in reviving the stock market and economic activity in the aftermath of the COVID-19 epidemic [ 72 , 73 ]. Continued economic transactions of goods and services within and outside the country would desensitize the adverse economic consequences of a COVID-19 pandemic [ 74 , 75 ].…”

The impact of COVID‐19 on logistics and coping strategies: A literature review

“…For curbing the COVID‐19 pandemic, Anser et al (2021) suggest several points for not interrupting the global healthcare supply chain, improving sustainable healthcare logistics activities, improving green supply chain processes, and the need for medical device transportation. Of course, effective policies do not end there; there are additional socioeconomic and environmental obligations that we must undertake.…”

“…To prevent the rapid spread of new outbreaks, governments across countries have put in place stringent measures that have put global supply chains at risk of serious disruptions, leading to severe shortages of essential goods such as biological drugs, and have also exposed the opacity of logistics processes and low elasticity of supply and demand for timely and sustained production (Kovács & Falagara Sigala, 2021). Anser et al (2021) found that COVID-19 increased healthcare expenditures and decreased corporate social responsibility (CSR), while increased coronavirus detection capacity reduced healthcare expenditures, boosted logistics activities, and increased CSR. The expanded coronavirus testing capability has lowered healthcare costs, increased logistics, and improved CSR.…”

When might host heterogeneity drive the evolution of asymptomatic, pandemic coronaviruses?

“…Economic disparities are especially likely to result not only in distinct transmission and infection risks among hosts, but also in variable public health attention and responses [ 9 , 17 , 34 , 38 , 57 , 88 , 122 ]. The lack of pharmaceutical interventions, and the heavy reliance on underfunded, or structurally adjusted, public institutions for disease control may exacerbate existing disparities in vulnerability to infection among host populations [ 4 , 22 , 79 , 120 , 129 ]. This is because non-pharmaceutical interventions, ranging from highly targeted case-detection and expansive contact-tracing to population-wide guidelines on physical distancing to lockdowns and economic shutdowns, require both a robust public health infrastructure and high social and economic development to implement successfully [ 9 , 33 , 40 , 46 , 48 , 53 , 54 , 71 , 87 , 137 , 141 ].…”